Nalaganje...
Pharmacokinetics of Alemtuzumab in Pediatric Patients Undergoing ex vivo T-Cell Depleted Haploidentical Hematopoietic Cell Transplantation
PURPOSE: Alemtuzumab is a humanized monoclonal antibody against CD52 which is predominantly present on T- and B-lymphocytes. Alemtuzumab has been used as part of conditioning regimens for prophylaxis against rejection and GVHD. While the mechanism of action is well-understood, the pharmacokinetics o...
Shranjeno v:
| izdano v: | Cancer Chemother Pharmacol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7735192/ https://ncbi.nlm.nih.gov/pubmed/33037919 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-020-04160-7 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|